SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-003108
Filing Date
2021-05-04
Accepted
2021-05-04 17:16:00
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050421p.htm 10-Q 434359
2 EXHIBIT 10.1 exh_101.htm EX-10.1 53418
3 EXHIBIT 31.1 exh_311.htm EX-31.1 10410
4 EXHIBIT 31.2 exh_312.htm EX-31.2 10451
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3704
6 EXHIBIT 32.2 exh_322.htm EX-32.2 3728
13 GRAPHIC logo.jpg GRAPHIC 6080
  Complete submission text file 0001171843-21-003108.txt   2999079

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE apto-20210331.xml EX-101.INS 511396
8 XBRL SCHEMA FILE apto-20210331.xsd EX-101.SCH 43310
9 XBRL CALCULATION FILE apto-20210331_cal.xml EX-101.CAL 29916
10 XBRL DEFINITION FILE apto-20210331_def.xml EX-101.DEF 249010
11 XBRL LABEL FILE apto-20210331_lab.xml EX-101.LAB 220377
12 XBRL PRESENTATION FILE apto-20210331_pre.xml EX-101.PRE 276598
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 21889815
SIC: 2836 Biological Products, (No Diagnostic Substances)